Characterizing patients with chronic heart failure in community care after hospitalization: a potential role for ivabradine

D. H. Elder, M. Mohan, L. Cochrane, H. Charles, C. C. Lang

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)


To identify the prevalence and characteristics of recently hospitalized chronic heart failure (CHF) patients in community care who meet the indication for ivabradine.|A retrospective clinical audit of CHF patients recently hospitalized with acute decompensated heart failure (ADHF) and subsequently referred to the Tayside Heart Failure Nurse Liaison Service (THFNLS), a Scottish nurse-led community heart failure liaison service. Inclusion criteria were previous hospitalization with ADHF, subsequent referral to the THFNLS, data for ≥ 2 nurse visits, and a recorded pulse. The main outcome measure was the proportion of patients who meet the indicated criteria for ivabradine.|In the UK, ivabradine is indicated for CHF with systolic dysfunction in patients in sinus rhythm, with a heart rate ≥ 75 bpm, and NYHA class II-class IV. After up-titration of a beta-blocker, 19.0% of patients in the full dataset (158 of 830) met the indication for ivabradine at the last visit. Of these "ivabradine-suitable" patients, 101 of 158 (63.9%) received bisoprolol "at any time" during the study period; 20 of 158 (12.7%) achieved the target dose (10 mg daily); 52 of 158 (32.9%) received 5 mg or 7.5 mg daily; and 93 of 158 (58.9%) received
Original languageEnglish
Pages (from-to)104-108
Number of pages5
JournalCardiovasc Ther
Issue number3
Publication statusPublished - 2015


  • Acute Disease Aged Aged, 80 and over Benzazepines Bisoprolol Cardiovascular Agents Chronic Disease Clinical Protocols Drug Utilization Female Heart Failure Hospitalization Humans Ivabradine Male Medication Therapy Management Middle Aged Retrospective Studies United Kingdom Beta-blockers Chronic heart failure Clinical audit Healthcare delivery Heart rate reduction Ivabradine


Dive into the research topics of 'Characterizing patients with chronic heart failure in community care after hospitalization: a potential role for ivabradine'. Together they form a unique fingerprint.

Cite this